home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9603.zip
/
M9630425.TXT
< prev
next >
Wrap
Text File
|
1996-02-27
|
2KB
|
27 lines
Document 0425
DOCN M9630425
TI Use of zidovudine in human immunodeficiency virus-induced hepatitis.
DT 9603
AU Wertheim DL; Valderamma E; Bonagura VR; Division of Allergy and
Immunology, Schneider Children's; Hospital, New Hyde Park, New York
11042, USA.
SO Clin Diagn Lab Immunol. 1994 May;1(3):361-3. Unique Identifier :
AIDSLINE MED/96050839
AB Hepatitis is a common complication of human immunodeficiency virus (HIV)
disease in children. Often a distinct pathogen cannot be identified.
Therefore, by exclusion, one must consider HIV the direct pathogen.
Zidovudine (AZT) has not been used as a treatment for HIV-positive
children with presumed HIV-induced hepatitis because of the potential of
this medication to exacerbate preexisting hepatitis. We have used AZT to
treat an 8-month-old female with severe HIV-induced hepatitis and have
achieved complete remission with this regimen. For some HIV-positive
children with HIV-induced hepatitis, AZT may be the drug of choice to
resolve hepatic inflammation caused by this virus.
DE Acquired Immunodeficiency Syndrome/*COMPLICATIONS Case Report Female
Hepatitis, Chronic Active/*DRUG THERAPY/*ETIOLOGY/PATHOLOGY Human
Infant Zidovudine/*THERAPEUTIC USE JOURNAL ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).